New blood test kit checked for accuracy and stability
NCT ID NCT06905392
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at a blood test kit called NTproBNP2, used on the AQT90 FLEX analyzer, which measures a substance linked to heart stress. Researchers wanted to see if the test works the same with different types of blood samples and how long those samples stay reliable. A total of 154 adults took part. The goal was to make sure the test gives consistent results for diagnosing heart conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
154 people
The number who actually took part.
- Started
-
May 2025
- Finished
-
Jan 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patient population with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study. * Subjects must be 18 years of age or older. * Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit. Exclusion Criteria: * Subjects known to be pregnant or breast-feeding. * Subjects previously enrolled in the study. * Subject, who has withdrawn consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diagnostic tests are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Universidad de Navarra
Pamplona, 31008, Spain
-
Hennepin Healthcare (Research Institute/ Minneapolis Medical Research Foundation)
Minneapolis, Minnesota, 55404, United States
-
Hospital Clinico Universitario de Santiago Compostela
Santiago de Compostela, Spain
-
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain
-
Servicio Andaluz de Salud (SAS) - Hospital San Juan de la Cruz
Ùbeda, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.